ASCVD Risk Estimator Plus
The updated ASCVD Risk Estimator Plus uses up to date science and user feedback to help a clinician and patient build a customized risk lowering plan by estimating and monitoring change in 10-year ASCVD risk.
Use the app to:
• Estimate a patient’s initial 10-year ASCVD risk using the pooled cohort equation
• Receive an individualized, risk-based, intervention approach
• Project the impact of specific interventions on a patient’s risk
• Guide clinician-patient discussion around customizing an intervention plan
• Update risk at follow-up based on a patient’s response to therapy using the Million Hearts Longitudinal model
Advice from the app is derived from the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease, the 2018 ACC/AHA et.al Guideline on the Management of Blood Cholesterol, the 2017 ACC/AHA et.al Guideline on High Blood Pressure in Adults, the 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk, and the 2016 Million Hearts Longitudinal ASCVD Risk Assessment Tool user guide. The information and recommendations in this app are meant to support clinical decision making. They are not meant to represent the only or best course of care, or replace clinical judgment. Therapeutic options should be determined after discussion between the patient and their care provider.
該應用程序構建通過監測10年ASCVD風險防範計劃。
更新的ASCVD Risk Estimator Plus使用最新的科學和用戶反饋，通過估計和監測10年ASCVD風險的變化，幫助臨床醫生和患者建立定制的風險降低計劃。
使用該應用程序：
•使用匯總隊列方程估計患者的最初10年ASCVD風險
•接受個性化，基於風險的干預方法
•預測特定乾預措施對患者風險的影響
•指導臨床醫生與患者討論定制干預計劃
•根據患者對使用百萬分之一縱向模型的治療反應，更新隨訪風險
該應用程序的建議來自2019年ACC / AHA心血管疾病一級預防指南，2018年ACC / AHA等血液膽固醇管理指南，2017年ACC / AHA等高血壓指南成人，2013年ACC / AHA心血管風險評估指南，以及2016年心臟縱向ASCVD風險評估工具用戶指南。此應用程序中的信息和建議旨在支持臨床決策。它們並不意味著代表唯一或最佳的護理過程，或取代臨床判斷。治療方案應在患者與其護理提供者討論後確定。